Method of treatment using papillomavirus L2 protein
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 30, 2002
Grant Date -
N/A
app pub date -
Jun 7, 1995
filing date -
Jun 26, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The L2 protein of papillomavirus (particularly BPV-2 and BPV-4) has been cloned as a fusion protein with beta-galactosidase and GST; both as the whole protein and as fragments. Vaccination of calves is found to have both a prophylactic effect in tumour prevention and a therapeutic effect in tumour regression.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully